NetworkNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Closes $18M IPO
Biofrontera (NASDAQ: BFRI, BFRIW), a biopharmaceutical company specializing in the commercialization of dermatological products, has closed its underwritten initial public offering of 3,600,000 units. According to the update, each unit consisted of (i) one share of common stock and (ii) one warrant to purchase a share of common stock, at a per-unit public offering price of $5.00. The warrants have an exercise price of $5.00 per share and are exercisable for five years after the issuance date. In addition, the underwriters exercised in full their option to purchase up to an additional 540,000 warrants. Roth Capital Partners acted as Joint…







